论文部分内容阅读
我院内科于1995年9～10月应用日本武田药厂生产的头孢甲肟（Cefmenoximehemihy－drochloride，简称cmx）治疗感染性疾病17例，均取得良好的疗效，现介绍于下。1．治疗对象：17例中13例为内科重病监护室（下称ICU）患者，4例为呼吸内科住院患者，均有严重或较严重的感染。男13例
Our hospital internal medicine in September 1995 to October Japan’s Takeda Pharmaceutical Cefmenoxime hymihy-drochloride (referred to as cmx) in the treatment of infectious diseases in 17 cases, have achieved good results, are presented below. 1. Treatment objects: 17 cases, 13 cases of medical intensive care unit (ICU) patients, 4 cases of respiratory patients in hospital, have serious or more serious infections. 13 males